Minimizing surgical blood loss at cesarean hysterectomy for placenta previa with evidence of placenta increta or placenta percreta: the state of play in 2020
- PMID: 32007492
- PMCID: PMC8725207
- DOI: 10.1016/j.ajog.2020.01.044
Minimizing surgical blood loss at cesarean hysterectomy for placenta previa with evidence of placenta increta or placenta percreta: the state of play in 2020
Abstract
The evolution of multidisciplinary team-based care for women with placenta accreta spectrum disorder has delivered stepwise improvements in clinical outcomes. Central to this overall goal is the ability to limit blood loss at surgery. Placement of inflatable balloons within the pelvic arteries, most commonly in the anterior divisions of the internal iliac arteries, became popular in many centers, at the expense of prolonging surgical care and with attendant risks of vascular injury. In tandem, the need to expose pelvic sidewall anatomy to safely identify the course of the ureters re-popularized the alternative strategy of ligating the same anterior divisions of the internal iliac arteries. With incremental gains in surgical expertise, described in 5 steps in this review, our teams have witnessed a steady decline in surgical blood loss. Nevertheless, a subset of women has the most severe form of placenta accreta spectrum, namely placenta previa-percreta. Such women are at risk of major hemorrhage during surgery from vessels arising outside the territories of the internal iliac arteries. These additional blood supplies, mostly from the external iliac arteries, pose significant risks of major blood loss even in experienced hands. To address this risk, some centers, principally in China, have adopted an approach of routinely placing an infrarenal aortic balloon, with both impressively low rates of blood loss and an ability to conserve the uterus by resecting the placenta with the affected portion of the uterine wall. We review these literature developments in the context of safely performing elective cesarean hysterectomy for placenta previa-percreta, the most severe placenta accreta spectrum disorder.
Keywords: cesarean hysterectomy; hemorrhage; infrarenal aortic balloon; internal iliac artery ligation; interventional radiology; magnetic resonance imaging; placenta accreta spectrum disorder.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors report no conflict of interest.
Figures



Similar articles
-
Temporary balloon occlusion of the internal iliac arteries for control of hemorrhage during cesarean hysterectomy in a patient with placenta previa and placenta increta.J Vasc Interv Radiol. 2000 May;11(5):622-4. doi: 10.1016/s1051-0443(07)61615-7. J Vasc Interv Radiol. 2000. PMID: 10834494 No abstract available.
-
Perioperative temporary occlusion of the internal iliac arteries as prophylaxis in cesarean section at risk of hemorrhage in placenta accreta.Cardiovasc Intervent Radiol. 2011 Aug;34(4):758-64. doi: 10.1007/s00270-011-0166-2. Epub 2011 May 20. Cardiovasc Intervent Radiol. 2011. PMID: 21598085
-
Risk factors for massive bleeding based on angiographic findings in patients with placenta previa and accreta who underwent balloon occlusion of the internal iliac artery during cesarean section.Br J Radiol. 2019 Oct;92(1102):20190127. doi: 10.1259/bjr.20190127. Epub 2019 Jul 23. Br J Radiol. 2019. PMID: 31317769 Free PMC article.
-
The effect prophylactic internal iliac artery balloon occlusion in patients with placenta previa or placental accreta spectrum: a systematic review and meta-analysis.Reprod Biol Endocrinol. 2021 Mar 4;19(1):40. doi: 10.1186/s12958-021-00722-3. Reprod Biol Endocrinol. 2021. PMID: 33663536 Free PMC article.
-
Clinical evaluation of the effect for prophylactic balloon occlusion in pregnancies complicated with placenta accreta spectrum disorder: A systematic review and meta-analysis.Int J Gynaecol Obstet. 2024 Oct;167(1):109-127. doi: 10.1002/ijgo.15704. Epub 2024 Jun 20. Int J Gynaecol Obstet. 2024. PMID: 38899567
Cited by
-
Prediction for Postpartum Hemorrhage of Placenta Previa Patients through MRI Using Self-Adaptive Edge Detection Algorithm.Contrast Media Mol Imaging. 2021 Aug 26;2021:8343002. doi: 10.1155/2021/8343002. eCollection 2021. Contrast Media Mol Imaging. 2021. PMID: 34526873 Free PMC article.
-
Nomogram to predict postpartum hemorrhage in cesarean delivery for twin pregnancies: a retrospective cohort study in China.Front Med (Lausanne). 2023 Apr 18;10:1139430. doi: 10.3389/fmed.2023.1139430. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37144027 Free PMC article.
-
A systematic review and meta-analysis of obstetric and maternal outcomes after prior uterine artery embolization.Sci Rep. 2021 Aug 19;11(1):16914. doi: 10.1038/s41598-021-96273-z. Sci Rep. 2021. PMID: 34413380 Free PMC article.
-
Doppler Parameters of Uterine Arteries in the Evaluation of Placenta Accreta in Patients with Placenta Previa.Int J Womens Health. 2025 Jul 18;17:2185-2193. doi: 10.2147/IJWH.S525365. eCollection 2025. Int J Womens Health. 2025. PMID: 40703856 Free PMC article.
-
Conservative management of placenta previa-percreta with bladder invasion: A case report.Clin Case Rep. 2024 May 7;12(5):e8879. doi: 10.1002/ccr3.8879. eCollection 2024 May. Clin Case Rep. 2024. PMID: 38721560 Free PMC article.
References
-
- Melcer Y, Jauniaux E, Maymon S, et al. Impact of targeted scanning protocols on peri-natal outcomes in pregnancies at risk of placenta accreta spectrum or vasa previa. Am J Obstet Gynecol 2018;218:443.e1–8. - PubMed
-
- Shamshirsaz AA, Fox KA, Erfani H, et al. Multidisciplinary team learning in the management of the morbidly adherent placenta: outcome improvements over time. Am J Obstet Gynecol 2017;216:612.e1–5. - PubMed
-
- Panaiotova J, Tokunaka M, Krajewska K, Zosmer N, Nicolaides KH. Screening for morbidly adherent placenta in early pregnancy. Ultrasound Obstet Gynecol 2019;53: 101–6. - PubMed
-
- Jauniaux E, Alfirevic Z, Bhide AG, et al. Placenta Praevia and placenta accreta: diagnosis and management: Green-top Guideline No. 27a. BJOG 2019;126:e1–48. - PubMed
-
- Hobson SR, Kingdom JC, Murji A, et al. No. 383—Screening, diagnosis, and management of placenta accreta spectrum disorders. J Obstet Gynaecol Can 2019;41:1035–49. - PubMed